A detailed history of Northern Trust Corp transactions in Volitionrx LTD stock. As of the latest transaction made, Northern Trust Corp holds 89,389 shares of VNRX stock, worth $54,527. This represents 0.0% of its overall portfolio holdings.

Number of Shares
89,389
Previous 89,546 0.18%
Holding current value
$54,527
Previous $64,000 4.69%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$0.72 - $1.19 $113 - $186
-157 Reduced 0.18%
89,389 $67,000
Q3 2023

Nov 13, 2023

BUY
$0.69 - $1.53 $13,423 - $29,764
19,454 Added 27.75%
89,546 $61,000
Q1 2023

May 15, 2023

BUY
$1.54 - $2.68 $14,237 - $24,776
9,245 Added 15.19%
70,092 $133,000
Q2 2022

Aug 12, 2022

SELL
$1.96 - $3.05 $4,649 - $7,234
-2,372 Reduced 3.75%
60,847 $125,000
Q2 2021

Aug 13, 2021

SELL
$3.01 - $3.78 $727,830 - $914,019
-241,804 Reduced 79.27%
63,219 $208,000
Q1 2021

May 12, 2021

SELL
$3.33 - $6.5 $44,825 - $87,496
-13,461 Reduced 4.23%
305,023 $1.15 Million
Q4 2020

Feb 11, 2021

BUY
$2.88 - $4.33 $61,369 - $92,267
21,309 Added 7.17%
318,484 $1.24 Million
Q3 2020

Nov 16, 2020

BUY
$2.94 - $4.05 $561,451 - $773,428
190,970 Added 179.81%
297,175 $954,000
Q2 2020

Aug 14, 2020

BUY
$2.89 - $4.32 $165,507 - $247,402
57,269 Added 117.03%
106,205 $413,000
Q1 2020

May 14, 2020

BUY
$2.47 - $5.16 $34,271 - $71,595
13,875 Added 39.57%
48,936 $152,000
Q4 2019

Feb 14, 2020

SELL
$4.28 - $5.95 $13,785 - $19,164
-3,221 Reduced 8.41%
35,061 $166,000
Q3 2019

Nov 13, 2019

BUY
$2.97 - $6.42 $742 - $1,605
250 Added 0.66%
38,282 $215,000
Q2 2018

Aug 14, 2018

BUY
$1.88 - $2.41 $7,973 - $10,220
4,241 Added 12.55%
38,032 $76,000
Q1 2018

May 09, 2018

BUY
$2.29 - $3.95 $25,366 - $43,754
11,077 Added 48.77%
33,791 $81,000
Q3 2017

Nov 13, 2017

BUY
$2.45 - $2.98 $55,649 - $67,687
22,714
22,714 $60,000

Others Institutions Holding VNRX

About VOLITIONRX LTD


  • Ticker VNRX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 57,297,000
  • Market Cap $35M
  • Description
  • VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...
More about VNRX
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.